ILCOCILLIN P.S. (200 MG+250MG)/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
ILCOCILLIN P.S. (200 MG+250MG)/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Authorised
- Dihydrostreptomycin sulfate
- Benzylpenicillin procaine monohydrate
Product identification
Medicine name:
ILCOCILLIN P.S. (200 MG+250MG)/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
- Dihydrostreptomycin sulfate
- Benzylpenicillin procaine monohydrate
Target species:
-
Cattle
-
Pig
-
Dog
-
Cat
-
Sheep
-
Goat
-
Sheep (for meat production)
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Dihydrostreptomycin sulfate250.00/milligram(s)1.00millilitre(s)
-
Benzylpenicillin procaine monohydrate200000.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal28day
-
Milk6dayINTRAMUSCULAR USE
-
Milk8daysubcutaneous use
-
-
Pig
-
Meat and offal28day
-
-
Dog
-
Not applicableno withdrawal period999 UNKNOWN
-
-
Cat
-
Not applicableno withdrawal period999 UNKNOWN
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Premier Shukuroglou Hellas S.A. Emporias Ktiniatrikon Farmakon
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories (Ireland) Limited
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 26783/08-04-2013/K-0045401
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet